Table 2 Demographic and laboratory characteristics of patients

 Females

16 (39%)

 Males

25 (61%)

Age, median (range)

36 (19–69)

Pleural TB cases

32 (78%)

  Culture

13 (41%)

  AFB microscopy +, ADA > 30 and clinical evidence

1 (3%)

  ADA > 30 and clinical evidence

17 (53%)

  Clinical evidence only^b

1 (3%)

 HIV positive

26 (81%)

 CD4+ T cell count HIV+, (n) median (range)^a

(22) 80 (7–328)

  CD4+ T cell count > 100 cells/microL

8 (36%)

  CD4+ T cell count < 100 cells/microL

14 (64%)

 ADA levels U/L (n) median (range)^a

(29) 62 (4–200)

Non-TB cases

9 (22%)

 Malignancy

3 (33%)

 Another non-TB condition ^c

6 (67%)

 HIV positive

5 (56%)

 CD4+ T cell count HIV+, (n) median (range)^a

(4) 119 (49–375)

  CD4+ T cell count > 100 cells/microL

3 (75%)

  CD4+ T cell count < 100 cells/microL

1 (25%)

 ADA levels U/L (n) median (range)a

(9) 15 (1–29)